Valuation of transfusion-free living in MDS: results of health utility interviews with patients

Abstract

Patients value TI, suggesting an important role for new treatments aiming to achieve greater TI in MDS. These results can be used in preference-based health economic evaluation of new MDS treatments, such as in future cost-utility studies.